Janux Therapeutics, Inc. (JANX)


Stock Price Forecast

April 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Janux Therapeutics, Inc. chart...

About the Company

We do not have any company description for Janux Therapeutics, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

9

Exchange

Nasdaq

$5M

Total Revenue

9

Employees

$2B

Market Capitalization

-35.81

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $JANX News

Which Is a Better Investment, Janux Therapeutics Inc or BIO-TECHNE Corp Stock?

7h ago, source: American Association of Individual Investors

Learn more about whether Janux Therapeutics Inc or BIO-TECHNE Corp is a better investment based on AAII's A+ Investor grades, ...

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

4d ago, source: Zacks.com on MSN

Shares of cancer-biotech Janux Therapeutics, Inc. JANX have surged close to 50% in the past week, following a report issued ...

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

on MSN ago, source:

Janux Therapeutics Inc (NASDAQ:JANX) shares are trading higher following Wednesday’s reports suggesting the company is ...

A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts

3d ago, source:

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $63.83, along ...

Janux Therapeutics Inc (JANX) Shares Soar Above 1-Year High

4d ago, source: newsheater

Reardon Tighe, the Acting Chief Financial Officer of Janux Therapeutics Inc, purchase 849,854 shares at $5.87 during a trade that took place back on Nov 13 ’23, which means that Reardon Tighe is ...

Commit To Purchase Janux Therapeutics At $25, Earn 26.5% Annualized Using Options

16d ago, source: Nasdaq

Investors eyeing a purchase of Janux Therapeutics Inc (Symbol: JANX) shares, but tentative about paying the going market price of $35.70/share, might benefit from considering selling puts among ...

Janux Therapeutics Inc Ordinary Shares

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Janux Therapeutics, Inc. (JANX)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Janux Therapeutics Inc Ordinary Shares JANX

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...